161 related articles for article (PubMed ID: 37941561)
1. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer.
Panthi B; Mohamed RM; Adrada BE; Boge M; Candelaria RP; Chen H; Hunt KK; Huo L; Hwang KP; Korkut A; Lane DL; Le-Petross HC; Leung JWT; Litton JK; Pashapoor S; Perez F; Son JB; Sun J; Thompson A; Tripathy D; Valero V; Wei P; White J; Xu Z; Yang W; Zhou Z; Yam C; Rauch GM; Ma J
Front Oncol; 2023; 13():1264259. PubMed ID: 37941561
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI.
Panthi B; Adrada BE; Candelaria RP; Guirguis MS; Yam C; Boge M; Chen H; Hunt KK; Huo L; Hwang KP; Korkut A; Lane DL; Le-Petross HC; Leung JWT; Litton JK; Mohamed RM; Musall BC; Pashapoor S; Patel MM; Perez F; Son JB; Thompson A; Valero V; Wei P; White J; Xu Z; Pinsky L; Tripathy D; Yang W; Ma J; Rauch GM
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831368
[TBL] [Abstract][Full Text] [Related]
3. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.
Hwang KP; Elshafeey NA; Kotrotsou A; Chen H; Son JB; Boge M; Mohamed RM; Abdelhafez AH; Adrada BE; Panthi B; Sun J; Musall BC; Zhang S; Candelaria RP; White JB; Ravenberg EE; Tripathy D; Yam C; Litton JK; Huo L; Thompson AM; Wei P; Yang WT; Pagel MD; Ma J; Rauch GM
Radiol Imaging Cancer; 2023 Jul; 5(4):e230009. PubMed ID: 37505106
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Musall BC; Adrada BE; Candelaria RP; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Santiago L; Whitman GJ; Moseley TW; Scoggins ME; Mahmoud HS; White JB; Hwang KP; Elshafeey NA; Boge M; Zhang S; Litton JK; Valero V; Tripathy D; Thompson AM; Yam C; Wei P; Moulder SL; Pagel MD; Yang WT; Ma J; Rauch GM
J Magn Reson Imaging; 2022 Dec; 56(6):1901-1909. PubMed ID: 35499264
[TBL] [Abstract][Full Text] [Related]
5. Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
Musall BC; Abdelhafez AH; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Le-Petross H; Arribas E; Lane DL; Spak DA; Leung JWT; Hwang KP; Son JB; Elshafeey NA; Mahmoud HS; Wei P; Sun J; Zhang S; White JB; Ravenberg EE; Litton JK; Damodaran S; Thompson AM; Moulder SL; Yang WT; Pagel MD; Rauch GM; Ma J
J Magn Reson Imaging; 2021 Jul; 54(1):251-260. PubMed ID: 33586845
[TBL] [Abstract][Full Text] [Related]
6. Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy.
Musall BC; Rauch DE; Mohamed RMM; Panthi B; Boge M; Candelaria RP; Chen H; Guirguis MS; Hunt KK; Huo L; Hwang KP; Korkut A; Litton JK; Moseley TW; Pashapoor S; Patel MM; Reed BJ; Scoggins ME; Son JB; Tripathy D; Valero V; Wei P; White JB; Whitman GJ; Xu Z; Yang WT; Yam C; Adrada BE; Ma J
J Magn Reson Imaging; 2024 Jan; ():. PubMed ID: 38294179
[TBL] [Abstract][Full Text] [Related]
7. A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer.
Jimenez JE; Abdelhafez A; Mittendorf EA; Elshafeey N; Yung JP; Litton JK; Adrada BE; Candelaria RP; White J; Thompson AM; Huo L; Wei P; Tripathy D; Valero V; Yam C; Hazle JD; Moulder SL; Yang WT; Rauch GM
Eur J Radiol; 2022 Apr; 149():110220. PubMed ID: 35193025
[TBL] [Abstract][Full Text] [Related]
8. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract][Full Text] [Related]
10. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
Adrada BE; Candelaria R; Moulder S; Thompson A; Wei P; Whitman GJ; Valero V; Litton JK; Santiago L; Scoggins ME; Moseley TW; White JB; Ravenberg EE; Yang WT; Rauch GM
Cancer; 2021 Aug; 127(16):2880-2887. PubMed ID: 33878210
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI.
Zhou Z; Adrada BE; Candelaria RP; Elshafeey NA; Boge M; Mohamed RM; Pashapoor S; Sun J; Xu Z; Panthi B; Son JB; Guirguis MS; Patel MM; Whitman GJ; Moseley TW; Scoggins ME; White JB; Litton JK; Valero V; Hunt KK; Tripathy D; Yang W; Wei P; Yam C; Pagel MD; Rauch GM; Ma J
Sci Rep; 2023 Jan; 13(1):1171. PubMed ID: 36670144
[TBL] [Abstract][Full Text] [Related]
12. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
[TBL] [Abstract][Full Text] [Related]
15. Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI.
Caballo M; Sanderink WBG; Han L; Gao Y; Athanasiou A; Mann RM
J Magn Reson Imaging; 2023 Jan; 57(1):97-110. PubMed ID: 35633290
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
[TBL] [Abstract][Full Text] [Related]
17. MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Wu C; Jarrett AM; Zhou Z; Elshafeey N; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Huo L; White JB; Tripathy D; Valero V; Litton JK; Yam C; Son JB; Ma J; Rauch GM; Yankeelov TE
Cancer Res; 2022 Sep; 82(18):3394-3404. PubMed ID: 35914239
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.
Xu H; Liu J; Chen Z; Wang C; Liu Y; Wang M; Zhou P; Luo H; Ren J
Eur Radiol; 2022 Jul; 32(7):4845-4856. PubMed ID: 35079887
[TBL] [Abstract][Full Text] [Related]
19. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs.
Zhou Z; Adrada BE; Candelaria RP; Elshafeey NA; Boge M; Mohamed RM; Pashapoor S; Sun J; Xu Z; Panthi B; Son JB; Guirguis MS; Patel MM; Whitman GJ; Moseley TW; Scoggins ME; White JB; Litton JK; Valero V; Hunt KK; Tripathy D; Yang W; Wei P; Yam C; Pagel MD; Rauch GM; Ma J
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083160
[TBL] [Abstract][Full Text] [Related]
20. Radiomics Based on Dynamic Contrast-Enhanced MRI to Early Predict Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Therapy.
Zeng Q; Ke M; Zhong L; Zhou Y; Zhu X; He C; Liu L
Acad Radiol; 2023 Aug; 30(8):1638-1647. PubMed ID: 36564256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
